Alliance A022104/NRG-GI010: A randomized phase II trial testing the efficacy of triplet versus doublet chemotherapy to achieve clinical complete response in patients with locally advanced rectal cancer—The Janus Rectal Cancer trial Meeting Abstract


Authors: Smith, J. J.; Dasari, A.; Shi, Q.; Garcia-Aguilar, J.; Sanoff, H. K.; George, T. J.; Hong, T. S.; Yothers, G.; Philip, P. A.; Nelson, G. D.; Al Baghdadi, T.; Alese, O. B.; O'Reilly, E. M.; Meyerhardt, J. A.; Shergill, A.; Horvat, N.; Romesser, P. B.; Hall, W. A.
Abstract Title: Alliance A022104/NRG-GI010: A randomized phase II trial testing the efficacy of triplet versus doublet chemotherapy to achieve clinical complete response in patients with locally advanced rectal cancer—The Janus Rectal Cancer trial
Meeting Title: 2023 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 41
Issue: 16 Suppl.
Meeting Dates: 2023 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2023-06-01
Language: English
DOI: 10.1200/JCO.2023.41.16_suppl.TPS3640
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: TPS3640 -- Meeting was also available virtually -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eileen O'Reilly
    780 O'Reilly
  2. Paul Bernard Romesser
    189 Romesser
  3. Jesse Joshua Smith
    217 Smith
  4. Natally Horvat
    101 Horvat
Related MSK Work